Gardi stated: "I hope I was able to help you with the recent patent transactions with the final rejection PTOL 326..It is a rejection that is from attorney and monies..Not the patent in it self.. "
That is TOTTALY false. The final rejection was based on the patent contents itself and specifically in reference to papers previously published by Jandu prior to the Small-Howard patent application regarding fibrin degradation products.
The patent attorney withdrawing is a separate issue.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.